Peptides, oil, recessions & an AMR crisis: Spinning out and building an anti-infectives biotech business

Deborah is the founder & CEO of NovaBiotics, a leading global biotechnology company developing anti-infective drug candidates for medically unmet infectious diseases. Deborah is editor of the European Biopharmaceutical Review & International Pharmaceutical Technology, a member of the Scottish Life Science Industry Leadership Group, Advisory Board of the Scottish Life Sciences Association, the Life Sciences board of Opportunity North East & a proud Trustee of Crohn’s in Childhood Research Association. In the seminar, Deborah will provide "case studies" of her experiences in the start-up and successful continuance of Novabiotics.